IL17A and experimental autoimmune encephalomyelitis: The blockade of Notch1 signaling by γ-secretase inhibitor resulted in the marked downregulation of Th17 cells, effective cytokine IL-17 secretion, and Th17-mediated disease progression in experimental autoimmune encephalomyelitis (EAE) [19].